DKSH has become a strategic partner for Lilly, a global healthcare leader to sell, market and distribute Lilly's brands in Singapore.
Media release
Singapore, January 17, 2020 – DKSH has sealed a strategic partnership with Eli Lilly and Company, a global healthcare leader and significant contributor to the healthcare industry in the Singapore market.
DKSH manages a range of over 15 brands from Lilly, mainly in the areas of oncology, diabetes, central nervous system (CNS), musculoskeletal and autoimmune diseases. This partnership expands the sales coverage, brand focus and depth of customer engagement to bring the benefits of Lilly's products to the many patients it serves.
“DKSH and Lilly share the vision and values to work together in bringing an innovative pipeline of products to more patients. With our in-depth knowledge of the local market as well as marketing and sales capabilities, DKSH will expand the access to reliable and affordable healthcare in Singapore,” said Dr. Varun Sethi, Vice President, Healthcare, Southeast Asia & Vietnam.
Rehan Saghir, General Manager for Lilly, ASEAN, added: “Lilly has many years of experience working with DKSH across ASEAN. Through this partnership, Lilly will strengthen its presence in Singapore. Together with DKSH, we look forward to expanding the access of Lilly products and to continuing to launch Lilly's innovative therapies in the fields of diabetes, oncology as well as immunology and pain in Singapore for the years to come.”
For further information please contact:
DKSH Singapore
Sabrina Ng
Manager, Branding and Communications
Phone +65 6471 1466
sabrina.hm.ng@dksh.com
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. The company was founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today it remains true to that mission in all its work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit: www.lilly.com.
About DKSH
DKSH is the leading Market Expansion Services provider with a focus on Asia. The Group helps other companies and brands to grow in the Consumer Goods, Healthcare, Performance Materials and Technology sectors. DKSH’s portfolio of services includes sourcing, market insights, marketing and sales, distribution and logistics as well as after-sales services. Publicly listed on the SIX Swiss Exchange, the Group operates in 35 markets with 33,000 specialists, generating net sales of CHF 11.3 billion in 2018. With its Swiss heritage and long business tradition since 1865, DKSH is deeply rooted in Asia Pacific.